Consensus definition of stage III non-small-cell lung cancer technical resectability to standardise inclusion criteria for clinical trials: a multisocietal EORTC-Lung Cancer Group collaboration.
AuteursDingemans AC, Opitz I, Brunelli A, Remon J, Hendriks LEL, Edwards J, Faivre-Finn C, Reguart N, Smit EF, Levy A, Sanchez-Lorente D, Trujillo JC, Filippi AR, Stathopoulos K, Blum TG, Guckenberger M, Popat S, De Angelis R, Hofman P, von der Thüsen J, Hartemink KJ, Petersen RH, Ruffini E, Dickhoff C, Houda I, Prisciandaro E, De Ruysscher D, Derks J, Bahce I, Mariolo A, Besse B, Xenophontos E, Giaj Levra N, van Schil P, Brandão M, Berghmans T
Risk of Post-Transplant Cyclophosphamide-Related Cardiotoxicity in Allogeneic Stem Cell Transplantation.
AuteursHadjali R, Chevillon F, Sibilia B, Pezel T, Toupin S, Dhedin N, Zhao LP, Baudet M, Benayoun M, Jestin M, Boissel N, Unger A, Sicre de Fontbrune F, Michonneau D, Xhaard A, Peffault de Latour R, Logeart D, Cohen-Solal A, Azibani F, Dillinger JG, Henry P, Robin M, Gonçalves T
ASO Visual Abstract: Health Care Utilization, Costs, and Cost-Effectiveness for Patients Undergoing Laparoscopic and Open Hemihepatectomy: A Secondary Analysis of the ORANGE II PLUS Randomised Controlled, Phase 3, Superiority Trial.
AuteursOlij B, Pilz da Cunha G, Kimman M, Ratti F, Abu Hilal M, Troisi RI, Sutcliffe RP, Besselink MG, Aroori S, Menon KV, Edwin B, D'Hondt M, Lucidi V, Ulmer TF, Díaz-Nieto R, Soonawalla Z, White S, Sergeant G, Coolsen MME, Kümmerli C, Scuderi V, Berrevoet F, Vanlander A, Marudanayagam R, Tanis PJ, Dewulf MJL, Fichtinger RS, Eminton ZB, Neumann UP, Brandts L, Pugh SA, Fretland ÅA, Primrose JN, van Dam RM
